Stock-Based Compensation and Other Benefit Plans (Tables)

12 Months Ended

Apr. 02, 2021

Share-based Payment Arrangement [Abstract]

Schedule of Restricted Stock Units Activities

RSUs

(In millions, except per share and year data)	Number of Shares	Weighted- Average Grant Date Fair Value
Outstanding as of April 3, 2020	7	$	21.33
Granted	4	$	20.70
Vested	(4)	$	21.86
Forfeited	(2)	$	20.55
Outstanding as of April 2, 2021	5	$	20.62

Schedule of PRUs Activity

PRUs

(In millions, except per share and year data)	Number of Shares	Weighted- Average Grant Date Fair Value
Outstanding and unvested at April 3, 2020	2	$	22.68
Granted	2	$	26.39
Vested	(2)	$	23.97
Forfeited	(1)	$	20.61
Unvested at April 2, 2021	1	$	27.50
Vested and unreleased at April 2, 2021	—
Outstanding at April 2, 2021	1

Schedule Of PRUs Valuation Assumptions

The valuation and the underlying weighted-average assumptions for PRUs are summarized below:

	Year Ended
	April 2, 2021			April 3, 2020			March 29, 2019
Expected term	2.7 years			1.9 years			2.7 years
Expected volatility	42.5		%	38.1		%	34.2		%
Risk-free interest rate	0.2		%	1.7		%	2.7		%
Expected dividend yield	—		%	1.1		%	—		%
Weighted-average grant date fair value of PRUs	$	26.39		$	21.69		$	21.30

Schedule of Stock Option Activities

Stock options

(In millions, except per share and year data)	Number of Shares	Weighted-Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Outstanding at April 3, 2020	2	$	6.85
Exercised	(1)	$	7.25
Forfeited and expired	(1)	$	6.93
Outstanding at April 2, 2021 (1)	—	$	5.22
Exercisable at April 2, 2021 (1)	—	$	5.22	4.75	$	5

(1) The number of shares is less than 1 million.

Schedule of ESPP Activities

The following table summarizes activity related to the purchase rights issued under the ESPP:

	Year Ended
(In millions)	April 2, 2021		April 3, 2020		March 29, 2019
Shares issued under the ESPP	1		2		—
Proceeds from issuance of shares	$	14	$	39	$	—

Schedule of Stock-based Compensation Expense

The following table summarizes the stock-based compensation expense recognized as a result of these modifications:

	Year Ended
(In millions)	April 2, 2021		April 3, 2020
Sales and marketing	$	2	$	6
Research and development	9		—
General and administrative	8		20
Restructuring and other costs	10		20
Discontinued operations	1		99
Total stock-based compensation	$	30	$	145

Total stock-based compensation expense and the related income tax benefit recognized for all of our equity incentive plans in our Consolidated Statements of Operations were as follows:

	Year Ended
(In millions)	April 2, 2021		April 3, 2020		March 29, 2019
Cost of revenues	$	1	$	2	$	6
Sales and marketing	18		29		42
Research and development	26		30		34
General and administrative	26		58		76
Restructuring, transition and other costs	10		20		—
Other income (expense), net	(1)		1		—
Total stock-based compensation from continuing operations	80		140		158
Discontinued operations	1		172		194
Total stock-based compensation expense	$	81	$	312	$	352
Income tax benefit for stock-based compensation expense	$	(18)	$	(55)	$	(73)

Schedule of Employer 401K Contributions

Our employer matching contributions to the 401(k) plan were as follows, including contributions to employees of our discontinued operations:

	Year Ended
(In millions)	April 2, 2021		April 3, 2020		March 29, 2019
401(k) matching contributions	$	3	$	16	$	23